Report Detail

Request for Sample of this report

Pharma & Healthcare Global Chlorpropamide Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4731763
    • |
  • 13 August, 2026
    • |
  • Global
    • |
  • 112 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Chlorpropamide market size was valued at US$ 158 million in 2025 and is forecast to a readjusted size of US$ 191 million by 2032 with a CAGR of 2.7% during review period.
Chlorpropamide is a first-generation sulfonylurea oral antidiabetic active pharmaceutical ingredient (API) used primarily for the treatment of Type 2 Diabetes by stimulating insulin secretion from pancreatic beta cells. Although its use has declined in many developed countries due to the availability of newer antidiabetic drugs, it remains an important legacy pharmaceutical compound and is still manufactured for certain markets. The Chlorpropamide supply chain begins with upstream chemical raw materials such as p-chlorobenzenesulfonamide, propylamine derivatives, chlorinated aromatic intermediates, sulfur-containing reagents, solvents, and pharmaceutical-grade catalysts. These materials are processed through multi-step organic synthesis, sulfonylation, purification, crystallization, drying, and quality-control procedures to produce pharmaceutical-grade Chlorpropamide API. Midstream activities involve API manufacturing, regulatory compliance, formulation development, and conversion into tablets and other oral dosage forms by pharmaceutical companies. Downstream sectors include generic drug manufacturers, hospitals, clinics, pharmacies, healthcare distributors, and patients requiring long-term blood glucose management, particularly in regions where first-generation sulfonylureas remain available as cost-effective therapeutic options. In 2025, global Chlorpropamide output was about 500 million units with 600 million units of capacity, average prices of USD 0.20–0.50 per unit, and gross margins around 42%.
This report is a detailed and comprehensive analysis for global Chlorpropamide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Chlorpropamide market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Chlorpropamide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Chlorpropamide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Chlorpropamide market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chlorpropamide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Chlorpropamide market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sun Pharmaceutical (India), Dr. Reddy's (India), Aurobindo Pharma (India), Lupin Limited (India), Zydus Lifesciences (India), Hetero Labs (India), MSN Laboratories (India), Huahai Pharmaceutical (China), Qilu Pharmaceutical (China), CSPC Pharmaceutical (China), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Chlorpropamide market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Immediate-Release
Modified-Release
Extended-Release
Market segment by Duration of Action
<12 hours
12–24 hours
24–60 hours
Market segment by Application
Human Pharmaceutical
Veterinary Pharmaceutical
Others
Major players covered
Sun Pharmaceutical (India)
Dr. Reddy's (India)
Aurobindo Pharma (India)
Lupin Limited (India)
Zydus Lifesciences (India)
Hetero Labs (India)
MSN Laboratories (India)
Huahai Pharmaceutical (China)
Qilu Pharmaceutical (China)
CSPC Pharmaceutical (China)
Hisun Pharmaceutical (China)
Livzon Pharmaceutical (China)
Polpharma (Poland)
F.I.S. Fabbrica (Italy)
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chlorpropamide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Chlorpropamide, with price, sales quantity, revenue, and global market share of Chlorpropamide from 2021 to 2026.
Chapter 3, the Chlorpropamide competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chlorpropamide breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Chlorpropamide market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Chlorpropamide.
Chapter 14 and 15, to describe Chlorpropamide sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Chlorpropamide Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Immediate-Release
    • 1.3.3 Modified-Release
    • 1.3.4 Extended-Release
  • 1.4 Market Analysis by Duration of Action
    • 1.4.1 Overview: Global Chlorpropamide Consumption Value by Duration of Action: 2021 Versus 2025 Versus 2032
    • 1.4.2 <12 hours
    • 1.4.3 12–24 hours
    • 1.4.4 24–60 hours
  • 1.5 Market Analysis by Application
    • 1.5.1 Overview: Global Chlorpropamide Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.5.2 Human Pharmaceutical
    • 1.5.3 Veterinary Pharmaceutical
    • 1.5.4 Others
  • 1.6 Global Chlorpropamide Market Size & Forecast
    • 1.6.1 Global Chlorpropamide Consumption Value (2021 & 2025 & 2032)
    • 1.6.2 Global Chlorpropamide Sales Quantity (2021-2032)
    • 1.6.3 Global Chlorpropamide Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Sun Pharmaceutical (India)
    • 2.1.1 Sun Pharmaceutical (India) Details
    • 2.1.2 Sun Pharmaceutical (India) Major Business
    • 2.1.3 Sun Pharmaceutical (India) Chlorpropamide Product and Services
    • 2.1.4 Sun Pharmaceutical (India) Chlorpropamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Sun Pharmaceutical (India) Recent Developments/Updates
  • 2.2 Dr. Reddy's (India)
    • 2.2.1 Dr. Reddy's (India) Details
    • 2.2.2 Dr. Reddy's (India) Major Business
    • 2.2.3 Dr. Reddy's (India) Chlorpropamide Product and Services
    • 2.2.4 Dr. Reddy's (India) Chlorpropamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Dr. Reddy's (India) Recent Developments/Updates
  • 2.3 Aurobindo Pharma (India)
    • 2.3.1 Aurobindo Pharma (India) Details
    • 2.3.2 Aurobindo Pharma (India) Major Business
    • 2.3.3 Aurobindo Pharma (India) Chlorpropamide Product and Services
    • 2.3.4 Aurobindo Pharma (India) Chlorpropamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Aurobindo Pharma (India) Recent Developments/Updates
  • 2.4 Lupin Limited (India)
    • 2.4.1 Lupin Limited (India) Details
    • 2.4.2 Lupin Limited (India) Major Business
    • 2.4.3 Lupin Limited (India) Chlorpropamide Product and Services
    • 2.4.4 Lupin Limited (India) Chlorpropamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Lupin Limited (India) Recent Developments/Updates
  • 2.5 Zydus Lifesciences (India)
    • 2.5.1 Zydus Lifesciences (India) Details
    • 2.5.2 Zydus Lifesciences (India) Major Business
    • 2.5.3 Zydus Lifesciences (India) Chlorpropamide Product and Services
    • 2.5.4 Zydus Lifesciences (India) Chlorpropamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Zydus Lifesciences (India) Recent Developments/Updates
  • 2.6 Hetero Labs (India)
    • 2.6.1 Hetero Labs (India) Details
    • 2.6.2 Hetero Labs (India) Major Business
    • 2.6.3 Hetero Labs (India) Chlorpropamide Product and Services
    • 2.6.4 Hetero Labs (India) Chlorpropamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Hetero Labs (India) Recent Developments/Updates
  • 2.7 MSN Laboratories (India)
    • 2.7.1 MSN Laboratories (India) Details
    • 2.7.2 MSN Laboratories (India) Major Business
    • 2.7.3 MSN Laboratories (India) Chlorpropamide Product and Services
    • 2.7.4 MSN Laboratories (India) Chlorpropamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 MSN Laboratories (India) Recent Developments/Updates
  • 2.8 Huahai Pharmaceutical (China)
    • 2.8.1 Huahai Pharmaceutical (China) Details
    • 2.8.2 Huahai Pharmaceutical (China) Major Business
    • 2.8.3 Huahai Pharmaceutical (China) Chlorpropamide Product and Services
    • 2.8.4 Huahai Pharmaceutical (China) Chlorpropamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Huahai Pharmaceutical (China) Recent Developments/Updates
  • 2.9 Qilu Pharmaceutical (China)
    • 2.9.1 Qilu Pharmaceutical (China) Details
    • 2.9.2 Qilu Pharmaceutical (China) Major Business
    • 2.9.3 Qilu Pharmaceutical (China) Chlorpropamide Product and Services
    • 2.9.4 Qilu Pharmaceutical (China) Chlorpropamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Qilu Pharmaceutical (China) Recent Developments/Updates
  • 2.10 CSPC Pharmaceutical (China)
    • 2.10.1 CSPC Pharmaceutical (China) Details
    • 2.10.2 CSPC Pharmaceutical (China) Major Business
    • 2.10.3 CSPC Pharmaceutical (China) Chlorpropamide Product and Services
    • 2.10.4 CSPC Pharmaceutical (China) Chlorpropamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 CSPC Pharmaceutical (China) Recent Developments/Updates
  • 2.11 Hisun Pharmaceutical (China)
    • 2.11.1 Hisun Pharmaceutical (China) Details
    • 2.11.2 Hisun Pharmaceutical (China) Major Business
    • 2.11.3 Hisun Pharmaceutical (China) Chlorpropamide Product and Services
    • 2.11.4 Hisun Pharmaceutical (China) Chlorpropamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Hisun Pharmaceutical (China) Recent Developments/Updates
  • 2.12 Livzon Pharmaceutical (China)
    • 2.12.1 Livzon Pharmaceutical (China) Details
    • 2.12.2 Livzon Pharmaceutical (China) Major Business
    • 2.12.3 Livzon Pharmaceutical (China) Chlorpropamide Product and Services
    • 2.12.4 Livzon Pharmaceutical (China) Chlorpropamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Livzon Pharmaceutical (China) Recent Developments/Updates
  • 2.13 Polpharma (Poland)
    • 2.13.1 Polpharma (Poland) Details
    • 2.13.2 Polpharma (Poland) Major Business
    • 2.13.3 Polpharma (Poland) Chlorpropamide Product and Services
    • 2.13.4 Polpharma (Poland) Chlorpropamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Polpharma (Poland) Recent Developments/Updates
  • 2.14 F.I.S. Fabbrica (Italy)
    • 2.14.1 F.I.S. Fabbrica (Italy) Details
    • 2.14.2 F.I.S. Fabbrica (Italy) Major Business
    • 2.14.3 F.I.S. Fabbrica (Italy) Chlorpropamide Product and Services
    • 2.14.4 F.I.S. Fabbrica (Italy) Chlorpropamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 F.I.S. Fabbrica (Italy) Recent Developments/Updates

3 Competitive Environment: Chlorpropamide by Manufacturer

  • 3.1 Global Chlorpropamide Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Chlorpropamide Revenue by Manufacturer (2021-2026)
  • 3.3 Global Chlorpropamide Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Chlorpropamide by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Chlorpropamide Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Chlorpropamide Manufacturer Market Share in 2025
  • 3.5 Chlorpropamide Market: Overall Company Footprint Analysis
    • 3.5.1 Chlorpropamide Market: Region Footprint
    • 3.5.2 Chlorpropamide Market: Company Product Type Footprint
    • 3.5.3 Chlorpropamide Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Chlorpropamide Market Size by Region
    • 4.1.1 Global Chlorpropamide Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Chlorpropamide Consumption Value by Region (2021-2032)
    • 4.1.3 Global Chlorpropamide Average Price by Region (2021-2032)
  • 4.2 North America Chlorpropamide Consumption Value (2021-2032)
  • 4.3 Europe Chlorpropamide Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Chlorpropamide Consumption Value (2021-2032)
  • 4.5 South America Chlorpropamide Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Chlorpropamide Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Chlorpropamide Sales Quantity by Type (2021-2032)
  • 5.2 Global Chlorpropamide Consumption Value by Type (2021-2032)
  • 5.3 Global Chlorpropamide Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Chlorpropamide Sales Quantity by Application (2021-2032)
  • 6.2 Global Chlorpropamide Consumption Value by Application (2021-2032)
  • 6.3 Global Chlorpropamide Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Chlorpropamide Sales Quantity by Type (2021-2032)
  • 7.2 North America Chlorpropamide Sales Quantity by Application (2021-2032)
  • 7.3 North America Chlorpropamide Market Size by Country
    • 7.3.1 North America Chlorpropamide Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Chlorpropamide Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Chlorpropamide Sales Quantity by Type (2021-2032)
  • 8.2 Europe Chlorpropamide Sales Quantity by Application (2021-2032)
  • 8.3 Europe Chlorpropamide Market Size by Country
    • 8.3.1 Europe Chlorpropamide Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Chlorpropamide Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Chlorpropamide Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Chlorpropamide Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Chlorpropamide Market Size by Region
    • 9.3.1 Asia-Pacific Chlorpropamide Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Chlorpropamide Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Chlorpropamide Sales Quantity by Type (2021-2032)
  • 10.2 South America Chlorpropamide Sales Quantity by Application (2021-2032)
  • 10.3 South America Chlorpropamide Market Size by Country
    • 10.3.1 South America Chlorpropamide Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Chlorpropamide Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Chlorpropamide Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Chlorpropamide Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Chlorpropamide Market Size by Country
    • 11.3.1 Middle East & Africa Chlorpropamide Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Chlorpropamide Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Chlorpropamide Market Drivers
  • 12.2 Chlorpropamide Market Restraints
  • 12.3 Chlorpropamide Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Chlorpropamide and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Chlorpropamide
  • 13.3 Chlorpropamide Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Chlorpropamide Typical Distributors
  • 14.3 Chlorpropamide Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Chlorpropamide. Industry analysis & Market Report on Chlorpropamide is a syndicated market report, published as Global Chlorpropamide Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Chlorpropamide market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo